Outcomes for Recurrent Mantle Cell Lymphoma post-Ibrutinib Therapy: A Retrospective Cohort Study from a Japanese Administrative Database
media
posted on 2022-07-28, 13:50 authored by Adis Rapid Journals on behalf of:, Shinya Rai, Yoshinori Tanizawa, Zhihong Cai, Yu-Jing Huang, Kaisa Taipale, Masaomi TajimiThe above graphical abstract represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).
© The authors, CC-BY-NC 2022.
